awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33400687-DBB19225-EDB9-4F64-AF3D-F4F863D58B70
Q33400687-DBB19225-EDB9-4F64-AF3D-F4F863D58B70
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33400687-DBB19225-EDB9-4F64-AF3D-F4F863D58B70
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m(2) every 21 days in patients with cancer
P577
Q33400687-DBB19225-EDB9-4F64-AF3D-F4F863D58B70
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33400687-DBB19225-EDB9-4F64-AF3D-F4F863D58B70
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
256eeff384f48a1f6d966af735f5aff466ea87bf
P577
2012-04-11T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
6644a7d5cd4f47da18105cc8d8d0aa01